** Shares of Proteomics International Laboratories Ltd
PIQ.AX rise as much as 6.8% to A$1.015 — hitting their highest
since Oct. 7, 2022
** Stock set to mark the best day since Dec. 22, 2022, if
gains hold
** Medical technology co says it has received CPT®
Proprietary Laboratory Analyses PLA code approval from
American Medical Association for it's PromarkerD test used to
assess the risk of diabetic kidney disease
** CPT PLA code enables healthcare providers to order,
facilitate and monitor test usages in the U.S.
** About 95,600 shares change hands compared with the 30-day
moving average of 46,800 shares
** PIQ fell 21.8% in 2022
(Reporting by Nausheen Thusoo in Bengaluru)
((Nausheen.Thusoo@thomsonreuters.com;))